Practice Areas



  • Roseman Achievement Award for Excellence in Research, Johns Hopkins University
  • University of Houston Law Center Dean’s Scholarship


  • State of Michigan, 2015
  • U.S. Patent and Trademark Office, 2010
  • State of Georgia, (inactive), 2009


University of Houston Law Center, J.D., 2009

The Johns Hopkins University, M.A., Ph.D., Bioinorganic Chemistry, 2004

University of California, Berkeley, M.S., Organic and Organometallic Chemistry,  1998

University of Michigan, B.S., Chemistry,  1995

Photo of Ian M. Wasser, Ph.D.

Ian M. Wasser, Ph.D.

248.524.2300, ext. 3109

Ian M. Wasser, Ph.D., is a registered patent attorney focused on preparing patent applications and managing their domestic and international prosecution. Ian’s patent practice is in the chemical arts with a focus on polymers, organometallic chemistry, materials science, and nanotechnologies. He primarily serves clients who are developing high performance specialty chemicals, electronic materials including LED and semiconductor materials, photolithography materials, automotive technologies, medical devices, and rechargeable batteries. In addition, he has experience evaluating and designing around existing products and patents, and counsels clients on matters of infringement, patentability, validity, and strategic patent portfolio management. 

Experience Highlights

Counsel, Cantor Colburn LLP, 2020-present

Associate, Cantor Colburn LLP, 2016-2019

Associate, Honigman Miller Schwartz and Cohn LLP, 2014-2016

Associate, Eversheds Sutherland LLP (formerly Sutherland Asbill & Brennan LLP), 2010-2014

Patent Engineer, Osha Liang, 2007

Postdoctoral Fellow, University of Texas – Austin, 2004-2005


Co-author, “Trademark Clearinghouse and the New gTLDs” (Legal Alert, March 28, 2013).

Co-author, “XXX Domains: Prevention is Better than the Cure” (Legal Alert, September 6, 2011).

Co-author, “ICANN Formally Adopts New Generic Top-Level Domain Name Program, Postpones Application Period” (Legal Alert, June 20, 2011).

Co-author, “New Generic Top-Level Domain Name Application Procedures are in the Home Stretch” (Legal Alert, June 14, 2011).

Co-author, “Unique Active Ingredient in Drug Product Can Mean Patent Term Extension” (Legal Alert, May 17, 2010).

Co-author, “Opinion Letters, Representation Issues, and the Impact of the Seagate and Knorr-Bremse Decisions,” PLI Patent Litigation 2010 Course Handbook #24179 (2010).

Co-author, “Copying Products is Risky Business: Inducing Patent Infringement” (Legal Alert, February 16, 2010).

Author, “Improving the Quality of Healthcare: Resolving Claim Disputes in Medicine,” Alternative Resolutions, Winter 2010, Vol. 19, No. 2, pp. 11-19.

Co-author, “Heme/Non-Heme Diiron (II) Complexes and O2, CO, and NO Adducts as Reduced and Substrate-Bound Models for the Active Site of Bacterial Nitric Oxide Reductase,” Journal of the American Chemical Society, 127, 3310-3320 (2005).

Co-author, “Efficient photodissociation of O2 from synthetic heme and heme/M (M=Fe, Cu) complexes, “Journal of the American Chemical Society, 126, 16712-16713 (2004).

Co-author, “Photochemical organic oxidations and dechlorinations with a mu-oxo bridged heme/non-heme diiron complex,” Inorganic Chemistry, 43, 8272-8281 (2004).

Co-author, “Synthesis and spectroscopy of micro-oxo (O(2)(-))-bridged heme/non-heme diiron complexes: models for the active site of nitric oxide reductase,” Inorganic Chemistry, 43, 651-662 (2004).

Co-author, “Superoxo, mu-peroxo, and mu-oxo complexes from heme/O2 and heme-Cu/O2 reactivity: copper ligand influences in cytochrome c oxidase models,” Proceedings of the National Academy of Sciences of USA, 100, 3623-3628 (2003).

Co-author, “Synthesis and crystal structures of (fulvalene)W(2)(SH)(2)(CO)(6), (fulvalene)W(2)(mu-S(2))(CO)(6), and (fulvalene)W(2)(mu-S)(CO)(6): low valent tungsten carbonyl sulfide and disulfide complexes stabilized by the bridging fulvalene ligand,” Inorganic Chemistry, 41, 3212-3217 (2002).

Co-author, “Nitric Oxide in Biological Denitrification: Fe/Cu Metalloenzyme and Metal Complex NOx Redox Chemistry,” Chemical Reviews, 102, 1201-1234 (2002).

Co-author, “Photosubstitution of (fulvalene)tetracarbonyldiruthenium by alkenes and alkynes: First observation of alkyne coupling on fulvalene dimetals and synthesis of a (fulvalene)dimetallacyclopentadiene(alkene) complex,” Organometallics, 21, 749-760 (2002).

Co-author, “Nitric Oxide Reductase from Paracoccus denitrificans contains an oxo-bridged heme/non-heme diiron center,” Journal of the American Chemical Society, 122, 9344-9345 (2000).

Co-author, “Metal Encapsulating Carbon Nanostructures from Oligoalkyne Metal Complexes,” Journal of the American Chemical Society, 121, 10430-10431 (1999).

Co-author, “Penta(cyclopentadienyl)-Ƞ5-cyclopentadienylmanganese tricarbonyl: Structure and laser-induced conversion to fullerenes,” Journal of Organometallic Chemistry, 572, 135-139 (1999).


Professional Affiliations

American Bar Association

State Bar of Michigan, Intellectual Property Law Section

State Bar of Georgia, Intellectual Property Law Section

American Chemical Society

Intellectual Property Owners Association